(149 days)
Not Found
No
The document describes a navigation system using electromagnetic tracking and image recording, with no mention of AI or ML technologies.
No
The device is described as assisting physicians with tools for electromagnetic tracking of instruments and providing quality control of scanning; it does not directly treat or diagnose a disease or condition.
No
The device is described as an "adjunct to handheld breast ultrasound to assist the physicians in their scanning process" and provides "quality control of scanning to provide an overall observation of scanning process." It aids in the scanning process but does not interpret or diagnose results itself.
No
The device description explicitly states that the system includes hardware components such as a Position Sensor Clip (electromagnetic), Sensor Transmitter, and Control Computer, in addition to the software.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs are used to examine specimens from the human body. The intended use and device description clearly state that BR-FHUS Navigation 1.0 is a software device that assists physicians with electromagnetic tracking of instruments in relation to breast ultrasound images. It is used in conjunction with a handheld ultrasound device, which is used to image the breast in vivo (within the living body).
- The device's function is navigation and quality control of the scanning process. It helps the physician track the ultrasound probe and visualize the scanned area on a route map. This is a tool for guiding the imaging process itself, not for analyzing biological samples or substances taken from the body.
The device is a medical device that aids in an imaging procedure, but it does not fit the definition of an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
BR-FHUS Navigation 1.0 is intended as a standalone software device installed on a standalone windows-based computer to assist physicians with tools for electromagnetic tracking of instruments in respect of breast ultrasound images generated from FDA cleared handheld ultrasound devices. The device is not intended to be used in the environment of strong magnetic or electromagnetic fields, such as in Magnetic Resonance Imaging (MRI) room. BR-FHUS Navigation 1.0 is indicated for use as an adjunct to handheld breast ultrasound to assist the physicians in their scanning process. The scanning paths are displayed on a route map and provide quality control of scanning to provide an overall observation of scanning process.
Product codes
IYO
Device Description
BR-FHUS Navigation 1.0 requires the following:
- Off-the-shelf PC Computer to run BR-FHUS Navigation 1.0, which meets the following requirements
- Minimum 500 GB Hard Drive
- Minimum Intel Core i5 6400 processor
- Operating System: Windows
- Minimum 8GB RAM
- 2 HDMI Ports
- 4 USB Ports of USB 2.0 or better
- Wired Ethernet
- Computer User Interface
- Keyboard
- Mouse
- Display
- Minimum display size 17"
- Minimum display resolution 1920*1080
- Off-the-shelf Image Capture Device
- PCI frame grabber card inserted into computer card slot of computer noted above or USB frame grabber device connected to computer by cable
- Video cable from ultrasound system to image capture device
- Off-the-shelf 3D electromagnetic tracking system (Ascension Technologies)
- Sensor position interface electronics (trakSTAR/driveBAY) connected to computer by cable
- Sensor position transmitter (Mid-Range Transmitter) and electronics connected to trakSTAR/driveBAY by cable
- Six degrees of freedom (6DOF) sensor (Model 800) and electronics connected to trakSTAR/driveBAY by cables
- Urethane clip for affixing a 6DOF sensor to ultrasound transducer
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Breast
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Skilled medical professionals
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance, Verification and Validation testing for BR-FHUS Navigation 1.0 was performed per internal procedures to ensure that all functional requirements have been met, and that core functions execute as expected. Testing was conducted in-house by trained personnel in a simulated workenvironment using breast phantoms to obtain the functional and accuracy test results.
The result of these tests demonstrates that BR-FHUS Navigation 1.0 validation is with in specification. As such, BR-FHUS Navigation 1.0 is as safe and effective as the predicate devices and is substantially equivalent to existing products on the market today.
In all instances, BR-FHUS Navigation 1.0 functioned as intended and the operation observed was as expected.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1560 Ultrasonic pulsed echo imaging system.
(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Public Health Service
Image /page/0/Picture/2 description: The image is a circular logo for the U.S. Department of Health & Human Services. The logo features the department's name encircling a stylized symbol. The symbol is a representation of a human figure, with three profiles layered on top of each other to create a sense of depth and dimension.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
September 29, 2017
TaiHao Medical Inc. % Chiu S. Lin, Ph.D. President Lin & Associates, LLC 5614 Johnson Avenue BETHESDA MD 20817
Re: K171309
Trade/Device Name: BR-FHUS Navigation 1.0 Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: II Product Code: IYO Dated: September 20, 2017 Received: September 20, 2017
Dear Dr. Lin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device
1
related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Michael D. O'Hara
For
Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K171309
Device Name BR-FHUS Navigation 1.0
Indications for Use (Describe)
BR-FHUS Navigation 1.0 is intended as a standalone software device installed on a standalone windows-based computer to assist physicians with tools for electromagnetic tracking of instruments in respect of breast ultrasound images generated from FDA cleared handheld ultrasound devices. The device is not intended to be used in the environment of strong magnetic or electromagnetic fields, such as in Magnetic Resonance Imaging (MRI) room. BR-FHUS Navigation 1.0 is indicated for use as an adjunct to handheld breast ultrasound to assist the physicians in their scanning process. The scanning paths are displayed on a route map and provide quality control of scanning to provide an overall observation of scanning process.
Type of Use (Select one or both, as applicable)
☑ Prescription Use (Part 21 CFR 801 Subpart D) |
---|
☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
TaiHao Medical Inc.
The Leader of Medical Software
5. 510(k) Summary of Safety and Effectiveness Information
5.1. Identification of Submitter:
Submitter: TaiHao Medical Inc.
Address: 3F .- 8, No.100, Sec. 2, Heping E. Rd., Da'an Dist., Taipei City 106, Taiwan (R.O.C.)
Phone: 886-2-2736-5679
Contact: HSIN HUNG (Simon) LAI
Title: President
886-2-2736-5679 Phone:
Email: simonlai(@taihaomed.com
Manufacturer: TaiHao Medical Inc.
US Agent and Contact: C Chiu S. Lin, Ph.D.
LIN & ASSOCIATES, LLC
Address: 5614 Johnson Avenue
Bethesda, MD 20817
Phone: (0) 301-591-3895
Email: cslin(@lin-associates.com
Date prepared: April 20, 2017
5.2. Identification of Product
Device Trade Name: BR-FHUS Navigation 1.0
Common and Usual Name: Ultrasonic Pulsed Echo Imaging System
Regulation Number: 21 CFR 892.1560
Classification Product Code: IYO
Classification: Class II
Predicate Device: Tractus TissueMapper Image Recording System (K131489)
4
The Leader of Medical Software
5.3. Intended Use / Indications for Use
BR-FHUS Navigation 1.0 is intended as a standalone software device installed on a standalone windows-based computer to assist physicians with tools for electromagnetic tracking of instruments in respect of breast ultrasound images generated from FDA cleared handheld ultrasound devices. The device is not intended to be used in the environment of strong magnetic or electromagnetic fields, such as in Magnetic Resonance Imaging (MRI) room. BR-FHUS Navigation 1.0 is indicated for use as an adjunct to handheld breast ultrasound to assist the physicians in their scanning process. The scanning paths are displayed on a route map and provide quality control of scanning to provide an overall observation of scanning process.
5.4. Technological Characteristics
BR-FHUS Navigation 1.0 requires the following:
- ◆ Off-the-shelf PC Computer to run BR-FHUS Navigation 1.0, which meets the following requirements
- Minimum 500 GB Hard Drive A
-
Minimum Intel Core i5 6400 processor
- Operating System: Windows A
- A Minimum 8GB RAM
-
2 HDMI Ports
-
4 USB Ports of USB 2.0 or better
-
Wired Ethernet
- ◆ Computer User Interface
- A Keyboard
- Mouse A
- A Display
- . Minimum display size 17"
- Minimum display resolution 1920*1080
5
The Leader of Medical Software
- ◆ Off-the-shelf Image Capture Device
-
PCI frame grabber card inserted into computer card slot of computer noted above or USB frame grabber device connected to computer by cable
-
Video cable from ultrasound system to image capture device
-
- ◆ Off-the-shelf 3D electromagnetic tracking system (Ascension Technologies)
-
Sensor position interface electronics (trakSTAR/driveBAY) connected to computer by cable
-
Sensor position transmitter (Mid-Range Transmitter) and electronics connected to trakSTAR/driveBAY by cable
-
Six degrees of freedom (6DOF) sensor (Model 800) and electronics connected to trakSTAR/driveBAY by cables
-
Urethane clip for affixing a 6DOF sensor to ultrasound transducer
-
5.5. Comparison with Predicate Devices
BR-FHUS Navigation 1.0 is substantially equivalent to Tractus TissueMapper Image Recording System (K131489) with a general intended use for recording ultrasound sequence images with probe's position. Minor technological characteristics differences do not raise any new questions of safety and effectiveness.
| | BR-FHUS Navigation 1.0,
k TBD | Tractus TissueMapper
Image Recording System,
K131489 |
|--------------------------------|-------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| Manufacturer | TaiHao Medical Inc. | Tractus Corporation |
| Regulation Number | 21 CFR 892.1560 | 21 CFR 892.1560 |
| Regulation Name | Ultrasonic Pulsed Echo
Imaging System | Ultrasonic Pulsed Echo
Imaging System |
| Product Code | IYO | IYO |
| Intended Use / Indications for | BR-FHUS Navigation 1.0 is
intended as a standalone | The Tractus TissueMapper
Image Recording System is |
| | | |
| Use | software device installed on a | intended to provide |
| | standalone windows-based | physicians with tools for |
| | computer to assist physicians | electromagnetic racking of |
| | with tools for electromagnetic | instruments with respect to |
| | tracking of instruments in | image data. |
| | respect of breast ultrasound | |
| | images generated from FDA | |
| | cleared handheld | |
| | ultrasound devices. The device | |
| | is not intended to be used in | |
| | the environment of strong | |
| | magnetic or electromagnetic | |
| | fields, such as in Magnetic | |
| | Resonance Imaging (MRI) | |
| | room. BR-FHUS Navigation | |
| | 1.0 is indicated for use as an | |
| | adjunct to handheld breast | |
| | ultrasound to assist the | |
| | physicians in their scanning | |
| | process. The scanning paths | |
| | are displayed on a route map | |
| | and provide quality control of | |
| | scanning to provide an overall | |
| | observation of scanning | |
| | process. | |
| User Population | Skilled medical professionals | Skilled medical professionals |
| Primary Components | Software: Position Sensor | Software: Position Sensor |
| | Monitoring, Image | Monitoring, Image |
| | presentation and recording, | presentation and recording, |
| | user interface. | user interface. |
| | Hardware: Position Sensor | Hardware: Position Sensor |
| | Clip (electromagnetic), Sensor | Clip (electromagnetic), |
| | Transmitter, Control | Sensor Transmitter, Control |
| | Computer. | Computer. |
| Accessories | Media storage (USB) | Media storage (USB) |
| Virtual Navigator Software | Yes | Yes |
| Primary Application | Small Parts (Breast) | Abdominal, Small Parts
(Breast) |
| Tracking System | Electromagnetic (Ascension) | Electromagnetic (Ascension) |
| Software | Yes | Yes |
| 3-D Rendering | No | Yes |
| Supported Imaging Modalities | Ultrasound | Ultrasound |
| Software Level of Concern | Moderate level of concern | Moderate level of concern |
| Image Archiving | Yes | Yes |
| Scanning Path Recording | Yes | Yes |
| Scanning Quality Control | Yes | No |
| Performance Testing | Results from software
verification and validation
testing performed per internal
procedures. | From the 510(k) Summary
that is available on the FDA
database, it appears that no
data from performance testing
was submitted. |
The comparison table between our device and the predicate devices is provided below:
6
TaiHao Medical Inc.
The Leader of Medical Software
7
The Leader of Medical Software
5.6. Performance Data
Performance, Verification and Validation testing for BR-FHUS Navigation 1.0 was performed per internal procedures to ensure that all functional requirements have been met, and that core functions execute as expected. Testing was conducted in-house by trained personnel in a simulated workenvironment using breast phantoms to obtain the functional and accuracy test results.
The result of these tests demonstrates that BR-FHUS Navigation 1.0 validation is with in specification. As such, BR-FHUS Navigation 1.0 is as safe and effective as the predicate devices and is substantially equivalent to existing products on the market today.
8
TaiHao Medical Inc.
The Leader of Medical Software
BR-FHUS Navigation 1.0 indications for use are drawn from the indications for use of a legally marketed predicate device: Tractus TissueMapper Image Recording System. BR-FHUS Navigation 1.0 draws from features of this predicate device. As such, the features provided by BR-FHUS Navigation 1.0 do not in themselves raise new concerns of safety or effectiveness.
In all instances, BR-FHUS Navigation 1.0 functioned as intended and the operation observed was as expected.
5.7. Substantial Equivalence
The intended use, technological characteristics, and major functionality of BR-FHUS Navigation 1.0. is similar to the predicate device. Neither new safety nor new effectiveness issues are introduced during or after using this device. The performance data generated, as described, demonstrates that our device is as safe and effective, as compared to the predicate device. Therefore, we believe BR-FHUS Navigation 1.0 is substantially equivalent to the predicate device.